Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo

Melanoma Research

Volumn 9, Issue 3, 1999, Pages 279-291

  Fujita, M ^a   Norris, D A ^a,b,c   Yagi, H ^a   Walsh, P ^a,c   Morelli, J G ^a,c   Weston, W L ^a,c   Terada, N ^d   Bennion, S D ^e   Robinson, W ^f   Lemon, M ^a   Maxwell, I H ^a,c   Yohn, J J ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CU Cancer Center   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e FITZSIMONS ARMY MEDICAL CENTER   (United States)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Invasion; Melanoma; Metastases; Migration; Ras; Vertical growth phase

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SKIN CANCER;

EID: 0032847433     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199906000-00010     Document Type: Article

References (49)

1. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987; 56: 461-474.
2. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985; 45: 5670-5676.
3. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-4689.
4. McCormick F. Ras GTPase activating protein: signal transmitter and signal terminator. Cell 1989; 56: 5-8.
5. van 't Veer IJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, Schrier PI, Bos JL. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989; 9: 31140-3116.
6. Jafari M, Papp T, Kirchner S, Diener U, Henschler D, Burg G, Schiffmann D. Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J Cancer Res Clin Oncol 1995; 121: 23-30.
7. Albino AP, Nanus DM, Mentle IR, et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989; 4: 1363-1374.
8. Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 1994; 102: 285-290.
9. Serrano M, Lee HW, Chin L, Cordon-Cardo C, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85: 27-37.
10. Herlyn M. Human melanoma: development and progression. Cancer Metastasis Rev 1990; 9: 101-112.
11. Souyri M, Koehne CF, O'Donnell PV, Aldrich TH, Furth ME, Fleissner E. Biological effects of a murine retro-virus carrying an activated n-ras gene of human origin. Virology 1987; 158: 69-78.
12. Cepko CL, Roberts BE, Mulligan RC. Construction and applications of a highly transmissible murine retro-virus shuttle vector. Cell 1984; 37: 1053-1062.
13. Goldfarb M, Shimizu K, Perucho M, Wigler M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 1982; 296: 404-409.
14. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912-915.
15. Wong TK, Neumann E. Electric field mediated gene transfer. Biochem Biophys Res Commun 1982; 107: 584-587.
16. Maxwell IH, Maxwell F. Electroporation of mammalian cells with a firefly luciferase expression plasmid: kinetics of transient expression differ markedly among cell types. DNA 1988; 7: 557-562.
17. Horikawa T, Norris DA, Yohn JJ, Zekman T, Travers JB, Morelli JG. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 1995; 104: 256-259.
18. Morelli JG, Kincannon J, Yohn JJ, Zekman T, Weston WL, Norris DA. Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992; 98: 290-295.
19. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-3245.
20. Florenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM. TGFB-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4b: evidence for cooperation between p21CIP1/WAF1 and p27KIP1. Oncogene 1996; 13: 2447-2457.
21. Valera A, Perales JC, Hatzoglou M, Bosch F. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther 1994; 5: 449-456.
22. Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA. Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J Natl Cancer Inst 1998; 90: 675-684.
23. Roberts TM. Cell biology: a signal chain of events. Nature 1992; 360: 534-535.
24. Satoh T, Kaziro Y. ras in signal transduction. Semin Cancer Biol 1992; 3: 169-177.
25. Castellano M, Gabrielli BG, Hussussain CJ, Dracopoli NC, Hayward NK. Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal. J Invest Dermatol 1997; 109: 61-68.
26. Freedman VH, Shin SI. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 1974; 3: 355-359.
27. Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Cell Biol 1993; 4: 953-961.
28. Bates RC, Lincz LF, Burns GF. Involvement of integrins in cell survival. Cancer Metastasis Rev 1995; 14: 191-203.
29. Norris DA, Middleton MH, Whang K, McGovern T, Bennion SD, David-Bajar K, Duke RC. Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro. Apoptosis 1997; 2: 136-148.
30. Norris DA, Whang K, David-Bajar K, Bennion SD. The influence of ultraviolet light on immunological cytotoxicity in the skin. Photochem Photobiol 1997; 65: 636-646.
31. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994; 127: 537-546.
32. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626.
33. Kapron-Bras C, Fitz-Gibbon L, Jeevaratnam P, Wilkins J, Dedhar S. Stimulation of tyrosine phosphorylation and accumulation of GTP-bound p21ras upon antibody-mediated alpha 2 beta 1 integrin activation in T-lymphoblastic cells. J Biol Chem 1993; 268: 20701-20704.
34. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 1994; 269: 26602-26605.
35. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786-791.
36. Liu B, Timar J, Howlett J, Diglio CA, Honn KV. Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul 1991; 2: 1045-1055.
37. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-239.
38. Rosen A, Keenan KF, Thelen M, Nairn AC, Aderem A. Activation of protein kinase C results in the displacement of its myristoylated, alanine-rich substrate from punctate structures in macrophage filopodia. J Exp Med 1990; 172: 1211-1215.
39. Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell 1992; 71: 713-716.
40. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70: 389-399.
41. Halaban R, Fan B, Ahn J, Funasaka Y, Gitay Goren H, Neufeld G. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother 1992; 12: 154-161.
42. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol 1993; 101: 605-608.
43. Etoh T, Thomas L, Pastel Levy C, Colvin RB, Mihm MC Jr, Byers HR. Role of integrin alpha 2 beta 1 (VLA-2) in the migration of human melanoma cells on laminin and type IV collagen. J Invest Dermatol 1993; 100: 640-647.
44. Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic pheno-type in transformed rat embryo cells. Proc Natl Acad Sci USA 1994; 91: 4293-4297.
45. Jansen B, Inoue SA, Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI, Pehamberger H. N-ras oncogene expression changes the growth characteristics of human melanoma in two independent scid-hu mouse models. Int J Cancer 1996; 67: 821-825.
46. Jansen B, Wadl H, Inoue SA, Trulzsch B, Selzer E, Duchene M, Eichler HG, Wolff K, Pehamberger H. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a non-antisense mechanism. Antisense Res Dev 1995; 5: 271-277.
47. Jansen B, Wadl H, Inoue SA, Trulzsch B, Selzer E, Duchene M, Eichler HG, Wolff K, Pehamberger H. Activated n-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis. Cancer Res 1997; 57: 362-365.
48. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q. Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
49. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Ecles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol 1995; 146: 1199-1206.